Ckd Bio (KO:063160) — Stock Price

₩14440.00 KRW
▲ 4.87% today

Ckd Bio (KO:063160) is currently trading at ₩14440.00 KRW, up 4.87% today. Over the past 52 weeks, shares have ranged between ₩12200.00 and ₩24500.00. This page tracks Ckd Bio's live share price on the KO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Ckd Bio.

Ckd Bio (063160) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Ckd Bio's daily closing share price and trading volume on the KO exchange over the past year, giving a clear view of recent price momentum and liquidity.

Ckd Bio Income Statement — Revenue, Profit & Earnings by Year

Ckd Bio's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ₩160.07 Billion ₩171.76 Billion ₩160.35 Billion ₩156.04 Billion ₩142.24 Billion
Cost of Revenue ₩131.29 Billion ₩135.81 Billion ₩152.34 Billion ₩139.25 Billion ₩128.93 Billion
Gross Profit ₩28.78 Billion ₩35.94 Billion ₩8.01 Billion ₩16.79 Billion ₩13.31 Billion
Research & Development ₩3.36 Billion ₩3.17 Billion ₩14.98 Billion ₩15.43 Billion ₩11.52 Billion
SG&A ₩6.80 Billion ₩6.66 Billion ₩6.59 Billion ₩9.14 Billion ₩6.94 Billion
Total Operating Expenses ₩156.47 Billion ₩160.80 Billion ₩180.51 Billion ₩170.85 Billion ₩153.67 Billion
Operating Income ₩3.61 Billion ₩10.95 Billion ₩-20.15 Billion ₩-14.81 Billion ₩-11.43 Billion
EBITDA — — — ₩2.29 Billion ₩5.56 Billion
EBIT — — — ₩-14.81 Billion ₩-11.43 Billion
Interest Expense ₩5.62 Billion ₩5.27 Billion ₩4.99 Billion ₩2.94 Billion ₩1.94 Billion
Income Before Tax ₩-2.97 Billion ₩9.22 Billion ₩-24.20 Billion ₩-18.59 Billion ₩-13.36 Billion
Income Tax Expense — — — ₩-1.89 Billion ₩-6.78 Billion
Net Income ₩-2.89 Billion ₩8.70 Billion ₩-24.19 Billion ₩-16.70 Billion ₩-6.58 Billion

Ckd Bio Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Ckd Bio's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ₩299.87 Billion ₩284.49 Billion ₩293.79 Billion ₩312.59 Billion ₩298.54 Billion
Total Current Assets ₩136.24 Billion ₩115.21 Billion ₩111.77 Billion ₩123.46 Billion ₩104.34 Billion
Cash & Equivalents — — — — —
Short-term Investments ₩70.20 Million ₩69.92 Million ₩69.55 Million ₩8.07 Billion ₩69.03 Million
Net Receivables ₩34.71 Billion ₩31.24 Billion ₩34.04 Billion ₩25.90 Billion ₩29.10 Billion
Inventory ₩96.77 Billion ₩80.54 Billion ₩69.08 Billion ₩78.51 Billion ₩70.36 Billion
Property, Plant & Equipment — — — ₩181.51 Billion ₩191.15 Billion
Goodwill — — — — —
Total Liabilities ₩172.83 Billion ₩153.48 Billion ₩170.76 Billion ₩164.79 Billion ₩137.05 Billion
Total Current Liabilities ₩152.04 Billion ₩90.68 Billion ₩98.62 Billion ₩81.59 Billion ₩44.31 Billion
Long-term Debt ₩17.25 Billion ₩59.91 Billion ₩69.43 Billion ₩80.37 Billion ₩89.27 Billion
Net Debt ₩141.47 Billion ₩128.96 Billion ₩141.59 Billion ₩132.02 Billion ₩105.12 Billion
Total Stockholder Equity ₩127.04 Billion ₩131.01 Billion ₩123.02 Billion ₩147.80 Billion ₩161.49 Billion
Retained Earnings ₩84.22 Billion ₩88.19 Billion ₩79.32 Billion ₩103.80 Billion ₩118.87 Billion

Ckd Bio Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Ckd Bio generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ₩-4.14 Billion ₩14.03 Billion ₩-7.22 Billion ₩-3.20 Billion ₩-5.88 Billion
Capital Expenditures ₩6.82 Billion ₩4.28 Billion ₩10.78 Billion ₩6.20 Billion ₩20.49 Billion
Free Cash Flow ₩-10.96 Billion ₩9.75 Billion ₩-18.00 Billion ₩-10.43 Billion ₩-26.59 Billion
Investing Cash Flow — — — ₩-20.55 Billion ₩-20.39 Billion
Financing Cash Flow — — — ₩24.96 Billion ₩28.27 Billion
Dividends Paid ₩-548.60 Million — — ₩548.60 Million ₩1.10 Billion
Stock-Based Compensation — — — — —
Depreciation ₩15.65 Billion ₩16.69 Billion ₩17.58 Billion ₩17.94 Billion ₩16.98 Billion
Change in Cash ₩332.30 Million ₩-2.54 Billion ₩-1.03 Billion ₩1.19 Billion ₩2.00 Billion

Ckd Bio Earnings History — EPS Actual vs. Analyst Estimates

Track Ckd Bio's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 23, 2026 -369.87 — —
Dec 31, 2025 -205.84 — —
Oct 23, 2025 -397.25 — —
Jul 24, 2025 -87.49 — —
Apr 24, 2025 164.09 — —
Mar 18, 2025 215.04 — —
Nov 14, 2024 51.99 — —
Aug 14, 2024 802.80 — —